Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck
- 7 January 2015
- journal article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 9 (3), 360-368
- https://doi.org/10.1007/s12105-014-0604-y
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)Cancer Treatment Reviews, 2014
- Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directionsCancer Treatment Reviews, 2014
- Use of p40 and p63 Immunohistochemistry and Human Papillomavirus Testing as Ancillary Tools for the Recognition of Head and Neck Sarcomatoid Carcinoma and Its Distinction From Benign and Malignant Mesenchymal ProcessesThe American Journal of Surgical Pathology, 2014
- Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysisTumor Biology, 2013
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysisInternational Journal of Cancer, 2007
- Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell CarcinomasJournal of Clinical Oncology, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005